Aloisine RP106 |
| Katalog-Nr.GC18386 |
Aloisine RP106 (Verbindung 38) ist ein potenter Inhibitor von Cdk1/Cyclin B, Cdk5/p25 und GSK3 mit IC50-Werten von 0,70 μM, 1,5 μM bzw. 0,92 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 496864-15-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Aloisine is an inhibitor of Cdk1/cyclin B, Cdk5/p25, and GSK3 (IC50s = 0.70, 1.5, and 0.92 uM, respectively). It is a derivative of the aloisines A and B, which competitively inhibit ATP binding to the catalytic subunit of CDKs and GSKs.
Review for Aloisine RP106
Average Rating: 5 (Based on Reviews and 7 reference(s) in Google Scholar.)
Review for Aloisine RP106
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *